The Global Summit on Bioavailability and Bioequivalence covers topics such as:
- BCS and BDDCS
- BCS and IVIVC Based Biowaivers
- Bioavailability and Bioequivalence
- Bio waivers based on BCS and IVIVC
- Clinical Pharmacology and Therapeutics
- Biosimilars and Biowaivers
- Drug Design and Development Challenges
- Clinical Research Vs Clinical Trails
- Factors Affecting Bioavailability
- Drug Metabolism and Drug Security
- Pharmaceutical Formulations
- Formulations and Modified Release Formulations
- Pharmacodynamic Endpoints for BE
- Pharmaceutical Metabolization
- Recent approaches to Biosimilars
- POPPK-PD and Pharmacometrics Applications to Assess BE
- Regulatory Science
- Recent biosimilars strategies
- Significance of BA/BE Studies
- Requirements for Regulatory Bioequivalence
- Trials in Clinical Pharmacology, Therapeutics, and Medicine
The Global Summit on Bioavailability and Bioequivalence will be held on 08-09 May 2024.
